US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Entrada Therapeutics, Inc.

11.29

-0.1200-1.05%

Post-market: 11.290.00000.00%16:10 EST

Volume:184.10K

Turnover:2.06M

Market Cap:431.50M

PE:-4.49

High:11.49

Open:11.35

Low:10.95

Close:11.41

52wk High:13.82

52wk Low:4.93

Shares:38.22M

Float Shares:21.58M

Volume Ratio:1.17

T/O Rate:0.85%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5151

EPS(LYR):1.68

ROE:-27.11%

ROA:-15.71%

PB:1.27

PE(LYR):6.72

Loading ...

Overview Company News Filings

Entrada Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Advancing DMD and DM1 Pipeline Positions Entrada for Multiple Near‑Term Catalysts and Upside Potential

Roth MKM Keeps Their Buy Rating on Entrada Therapeutics Inc (TRDA)

Entrada Therapeutics: Advancing ENTR-601-44 Positions Platform for Best-in-Class Dystrophin Restoration and Attractive Risk/Reward

BRIEF-Entrada Therapeutics Inc On Track To Report Elevate-44-201 Cohort 1 Data In Q2 2026, Cohort 2 Data By End Of Year

Entrada Therapeutics Inc - Intends to Open Expansion Cohort Later This Year in Elevate-44-201 Study

THOMSON REUTERS

Entrada Therapeutics Advances ELEVATE-44-201 Study to Higher Dose for Duchenne Muscular Dystrophy

Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study

Entrada Therapeutics Initiated at Buy by Guggenheim

Guggenheim Initiates Coverage on Entrada Therapeutics With Buy Rating, $20 Price Target

MT Newswires Live

Entrada Therapeutics to Present at Upcoming Investor Conferences

Oppenheimer Initiates Coverage on Entrada Therapeutics With Outperform Rating, $21 Price Target

MT Newswires Live

Entrada Therapeutics: Advancing DMD and DM1 Pipeline with Emerging Ophthalmology Assets Supports Buy Rating and $20 Target

Entrada Therapeutics unveils pipeline advances for Duchenne and myotonic dystrophy therapies

Entrada Therapeutics reports progress across development portfolio

Entrada Therapeutics Inc - Has Cash Runway Into Q3 2027

THOMSON REUTERS

Entrada Therapeutics Inc - Expects to Initiate Global Phase 1/2 Mad Clinical Study of Entr-601-50 by End of 2026

THOMSON REUTERS

Entrada Therapeutics Inc - on Track to Report Elevate-44-201 Data From First Cohort in Q2 2026 and Elevate-45-201 Data From First Cohort in Mid-2026

THOMSON REUTERS

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

Entrada Therapeutics Unveils Pipeline Progress and Clinical Milestones for Duchenne and Myotonic Dystrophy Programs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TRDA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRDA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRDA\",,,,,undefined,":{"symbol":"TRDA","market":"US","secType":"STK","nameCN":"Entrada Therapeutics, Inc.","latestPrice":11.29,"timestamp":1771621200000,"preClose":11.41,"halted":0,"volume":184098,"hourTrading":{"tag":"盘后","latestPrice":11.29,"preClose":11.29,"latestTime":"16:10 EST","volume":927,"amount":10465.83,"timestamp":1771621804643,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.010517090271691586,"floatShares":21582000,"shares":38219232,"eps":-2.51511,"marketStatus":"Market Closed","change":-0.12,"latestTime":"02-20 16:00:00 EST","open":11.35,"high":11.49,"low":10.95,"amount":2061341.048944,"amplitude":0.047327,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.51511,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":11.41,"postHourTrading":{"tag":"盘后","latestPrice":11.29,"preClose":11.29,"latestTime":"16:10 EST","volume":927,"amount":10465.83,"timestamp":1771621804643,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1697347374507414,"impliedVol":0.3926,"impliedVolPercentile":0.2032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRDA\",,,,,undefined,":{"symbol":"TRDA","floatShares":21582000,"roa":"-15.71%","roe":"-27.11%","lyrEps":1.68,"volumeRatio":1.1697347374507414,"shares":38219232,"dividePrice":0,"high":11.49,"amplitude":0.047327,"preClose":11.41,"low":10.95,"week52Low":4.93,"pbRate":"1.27","psRate":"7.01","week52High":13.82,"institutionHeld":0,"latestPrice":11.29,"eps":-2.51511,"divideRate":0,"volume":184098,"delay":0,"ttmEps":-2.51511,"open":11.35,"prevYearClose":10.28,"prevWeekClose":10.88,"prevMonthClose":11.44,"prevQuarterClose":10.28,"fiveDayClose":10.8,"twentyDayClose":11.71,"sixtyDayClose":10.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRDA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"TRDA","fiscalQuarterEnding":"2025/09","expectedEps":-1.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-1.06},{"market":"US","date":"2025-08-06","symbol":"TRDA","fiscalQuarterEnding":"2025/06","expectedEps":-0.86,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-1.04},{"market":"US","date":"2025-05-08","symbol":"TRDA","fiscalQuarterEnding":"2025/03","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2025-02-27","symbol":"TRDA","fiscalQuarterEnding":"2024/12","expectedEps":-0.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2024-11-05","symbol":"TRDA","fiscalQuarterEnding":"2024/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"pre","actualEps":-0.35}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRDA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRDA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1770786000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRDA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRDA","date":"2026-02-20","current":-4.488869,"percent":0.566288,"low":-69.405148,"twenty":-7.508508,"median":-4.762744,"eighty":5.800117,"high":25.975557,"avg":-4.926128,"sd":15.323551,"marketCap":409180365},"quantilePoints":[{"date":"2021-10-29","current":-7.394936,"twenty":-17.597525,"median":-17.597525,"eighty":-11.475972,"marketCap":251013723},{"date":"2021-11-05","current":-21.790051,"twenty":-21.952046,"median":-20.803996,"eighty":-17.597525,"marketCap":739641498},{"date":"2021-11-12","current":-28.525158,"twenty":-25.58108,"median":-21.983741,"eighty":-18.485692,"marketCap":968257962},{"date":"2021-11-19","current":-28.868516,"twenty":-29.41789,"median":-24.54132,"eighty":-20.606786,"marketCap":979912918},{"date":"2021-11-26","current":-25.452541,"twenty":-28.824496,"median":-24.607351,"eighty":-21.353369,"marketCap":863961039},{"date":"2021-12-03","current":-23.533255,"twenty":-28.623764,"median":-25.505365,"eighty":-21.812942,"marketCap":798812818},{"date":"2021-12-10","current":-15.265518,"twenty":-28.187082,"median":-23.647708,"eighty":-19.069596,"marketCap":631748205},{"date":"2021-12-17","current":-11.577357,"twenty":-26.820692,"median":-22.432748,"eighty":-16.202556,"marketCap":479117339},{"date":"2021-12-23","current":-12.836913,"twenty":-26.764346,"median":-21.904504,"eighty":-14.360448,"marketCap":531242809},{"date":"2021-12-31","current":-12.912336,"twenty":-26.676305,"median":-20.53107,"eighty":-13.447835,"marketCap":534364094},{"date":"2022-01-07","current":-8.930026,"twenty":-26.218494,"median":-18.937535,"eighty":-12.769033,"marketCap":369560215},{"date":"2022-01-14","current":-6.516506,"twenty":-25.584602,"median":-17.597525,"eighty":-11.577357,"marketCap":269679075},{"date":"2022-01-21","current":-6.101682,"twenty":-25.577558,"median":-15.559666,"eighty":-10.093042,"marketCap":252512005},{"date":"2022-01-28","current":-7.021837,"twenty":-25.519451,"median":-14.360448,"eighty":-7.766209,"marketCap":290591689},{"date":"2022-02-04","current":-7.715724,"twenty":-25.463106,"median":-13.5308,"eighty":-7.379146,"marketCap":319307516},{"date":"2022-02-11","current":-8.537829,"twenty":-24.100237,"median":-13.16123,"eighty":-7.512789,"marketCap":353329529},{"date":"2022-02-18","current":-11.275667,"twenty":-23.579036,"median":-12.802973,"eighty":-7.548286,"marketCap":466632197},{"date":"2022-02-25","current":-9.126125,"twenty":-23.517408,"median":-12.086459,"eighty":-7.649352,"marketCap":377675557},{"date":"2022-03-04","current":-7.813773,"twenty":-22.862386,"median":-11.577357,"eighty":-7.720249,"marketCap":323365188},{"date":"2022-03-11","current":-6.388288,"twenty":-22.163344,"median":-11.204016,"eighty":-7.720249,"marketCap":264372890},{"date":"2022-03-18","current":-6.017184,"twenty":-21.936199,"median":-10.78542,"eighty":-7.363356,"marketCap":307827117},{"date":"2022-03-25","current":-6.255428,"twenty":-21.835832,"median":-10.117931,"eighty":-6.952448,"marketCap":320015196},{"date":"2022-04-01","current":-5.638438,"twenty":-21.46254,"median":-9.64654,"eighty":-6.638691,"marketCap":288451197},{"date":"2022-04-08","current":-4.502198,"twenty":-20.388445,"median":-9.144981,"eighty":-6.309439,"marketCap":230323437},{"date":"2022-04-14","current":-4.948141,"twenty":-19.729901,"median":-9.028075,"eighty":-6.17703,"marketCap":253137020},{"date":"2022-04-22","current":-4.107655,"twenty":-19.333718,"median":-8.726386,"eighty":-6.029276,"marketCap":210139396},{"date":"2022-04-29","current":-3.666235,"twenty":-18.754411,"median":-8.454865,"eighty":-5.912113,"marketCap":187557252},{"date":"2022-05-06","current":-3.457787,"twenty":-18.126844,"median":-8.349273,"eighty":-5.760614,"marketCap":176893461},{"date":"2022-05-13","current":-2.854496,"twenty":-17.597525,"median":-7.941992,"eighty":-5.364762,"marketCap":183969409},{"date":"2022-05-20","current":-2.883329,"twenty":-16.900041,"median":-7.813773,"eighty":-4.563286,"marketCap":185827686},{"date":"2022-05-27","current":-3.373495,"twenty":-15.618496,"median":-7.753435,"eighty":-4.36536,"marketCap":217418392},{"date":"2022-06-03","current":-3.200495,"twenty":-15.214231,"median":-7.632759,"eighty":-4.157927,"marketCap":206268731},{"date":"2022-06-10","current":-4.55566,"twenty":-14.879355,"median":-7.394936,"eighty":-4.140761,"marketCap":293607743},{"date":"2022-06-17","current":-4.11355,"twenty":-14.259382,"median":-7.131199,"eighty":-4.140761,"marketCap":265114165},{"date":"2022-06-24","current":-4.714243,"twenty":-13.855117,"median":-6.935101,"eighty":-4.15057,"marketCap":303828266},{"date":"2022-07-01","current":-5.766658,"twenty":-13.576054,"median":-6.811331,"eighty":-4.187355,"marketCap":371655372},{"date":"2022-07-08","current":-5.656131,"twenty":-13.503648,"median":-6.516506,"eighty":-4.216733,"marketCap":364531977},{"date":"2022-07-15","current":-5.209215,"twenty":-13.455377,"median":-6.350577,"eighty":-4.227922,"marketCap":335728686},{"date":"2022-07-22","current":-5.233243,"twenty":-13.218551,"median":-6.255428,"eighty":-4.255794,"marketCap":337277250},{"date":"2022-07-29","current":-6.151102,"twenty":-12.962115,"median":-6.178897,"eighty":-4.266149,"marketCap":396432396},{"date":"2022-08-05","current":-5.21402,"twenty":-12.851998,"median":-6.151102,"eighty":-4.298784,"marketCap":336038398},{"date":"2022-08-12","current":-5.083828,"twenty":-12.782609,"median":-6.05057,"eighty":-4.359782,"marketCap":395150717},{"date":"2022-08-19","current":-5.22471,"twenty":-12.238059,"median":-6.026259,"eighty":-4.396116,"marketCap":406101054},{"date":"2022-08-26","current":-5.860692,"twenty":-12.075145,"median":-5.963285,"eighty":-4.405727,"marketCap":455534002},{"date":"2022-09-02","current":-5.309239,"twenty":-11.675406,"median":-5.919443,"eighty":-4.443999,"marketCap":412671256},{"date":"2022-09-09","current":-6.005599,"twenty":-11.577357,"median":-5.919443,"eighty":-4.466633,"marketCap":466797205},{"date":"2022-09-16","current":-5.599054,"twenty":-11.396343,"median":-5.874796,"eighty":-4.487556,"marketCap":435197663},{"date":"2022-09-23","current":-6.074028,"twenty":-11.266616,"median":-5.860692,"eighty":-4.499555,"marketCap":472115940},{"date":"2022-09-30","current":-6.343716,"twenty":-11.192702,"median":-5.898062,"eighty":-4.525626,"marketCap":493078013},{"date":"2022-10-07","current":-5.961322,"twenty":-11.10672,"median":-5.888899,"eighty":-4.547138,"marketCap":463355671},{"date":"2022-10-14","current":-6.243086,"twenty":-10.903079,"median":-5.892909,"eighty":-4.553823,"marketCap":485256344},{"date":"2022-10-21","current":-7.587503,"twenty":-10.513899,"median":-5.919443,"eighty":-4.571231,"marketCap":589753842},{"date":"2022-10-28","current":-9.117079,"twenty":-10.255954,"median":-5.957297,"eighty":-4.615058,"marketCap":708643211},{"date":"2022-11-04","current":-8.909464,"twenty":-10.100584,"median":-5.973297,"eighty":-4.663727,"marketCap":692505938},{"date":"2022-11-11","current":-6.743676,"twenty":-9.96784,"median":-6.011392,"eighty":-4.695302,"marketCap":596370284},{"date":"2022-11-18","current":-6.332606,"twenty":-9.758166,"median":-6.033802,"eighty":-4.710399,"marketCap":560017708},{"date":"2022-11-25","current":-5.226969,"twenty":-9.516814,"median":-6.017184,"eighty":-4.72039,"marketCap":462241813},{"date":"2022-12-02","current":-6.488529,"twenty":-9.262707,"median":-6.011392,"eighty":-4.755372,"marketCap":573806616},{"date":"2022-12-09","current":-6.757851,"twenty":-9.16356,"median":-6.033802,"eighty":-4.809238,"marketCap":597623821},{"date":"2022-12-16","current":-7.505574,"twenty":-9.145735,"median":-6.049635,"eighty":-4.867597,"marketCap":663747905},{"date":"2022-12-23","current":-5.304931,"twenty":-9.135788,"median":-6.033802,"eighty":-4.931786,"marketCap":469136267},{"date":"2022-12-30","current":-4.791093,"twenty":-9.127349,"median":-6.017184,"eighty":-4.849836,"marketCap":423695546},{"date":"2023-01-06","current":-5.04624,"twenty":-9.126125,"median":-6.001574,"eighty":-4.798181,"marketCap":446259214},{"date":"2023-01-13","current":-4.858424,"twenty":-9.117079,"median":-5.963335,"eighty":-4.832074,"marketCap":429649847},{"date":"2023-01-20","current":-4.737938,"twenty":-9.004373,"median":-5.936357,"eighty":-4.79343,"marketCap":418994782},{"date":"2023-01-27","current":-4.273712,"twenty":-8.93926,"median":-5.907226,"eighty":-4.785423,"marketCap":377941441},{"date":"2023-02-03","current":-5.10294,"twenty":-8.913576,"median":-5.876808,"eighty":-4.726537,"marketCap":451273363},{"date":"2023-02-10","current":-5.73372,"twenty":-8.859542,"median":-5.853158,"eighty":-4.736273,"marketCap":507055765},{"date":"2023-02-17","current":-3.919341,"twenty":-8.845264,"median":-5.829192,"eighty":-4.699967,"marketCap":346603013},{"date":"2023-02-24","current":-3.926429,"twenty":-8.842391,"median":-5.815955,"eighty":-4.628083,"marketCap":347229782},{"date":"2023-03-03","current":-3.766962,"twenty":-8.772142,"median":-5.776163,"eighty":-4.547138,"marketCap":333127489},{"date":"2023-03-10","current":-4.254453,"twenty":-8.615439,"median":-5.76082,"eighty":-4.499555,"marketCap":402539289},{"date":"2023-03-17","current":-5.429059,"twenty":-8.539287,"median":-5.747436,"eighty":-4.511816,"marketCap":513675855},{"date":"2023-03-24","current":-5.271746,"twenty":-8.488051,"median":-5.734949,"eighty":-4.524607,"marketCap":498791493},{"date":"2023-03-31","current":-5.068986,"twenty":-8.454865,"median":-5.728214,"eighty":-4.53629,"marketCap":479607205},{"date":"2023-04-06","current":-4.883706,"twenty":-8.451848,"median":-5.696978,"eighty":-4.543209,"marketCap":462076735},{"date":"2023-04-14","current":-5.932462,"twenty":-8.421679,"median":-5.680564,"eighty":-4.551986,"marketCap":561305812},{"date":"2023-04-21","current":-5.257762,"twenty":-8.349273,"median":-5.670547,"eighty":-4.55566,"marketCap":497468439},{"date":"2023-04-28","current":-4.805367,"twenty":-8.340215,"median":-5.658534,"eighty":-4.562088,"marketCap":454664626},{"date":"2023-05-05","current":-4.191543,"twenty":-8.062667,"median":-5.64652,"eighty":-4.528859,"marketCap":396587028},{"date":"2023-05-12","current":-5.064425,"twenty":-7.979703,"median":-5.633268,"eighty":-4.502198,"marketCap":403224467},{"date":"2023-05-19","current":-5.277006,"twenty":-7.913544,"median":-5.617686,"eighty":-4.518228,"marketCap":420149939},{"date":"2023-05-26","current":-4.970025,"twenty":-7.90428,"median":-5.592298,"eighty":-4.528859,"marketCap":395708454},{"date":"2023-06-02","current":-4.76989,"twenty":-7.868078,"median":-5.581432,"eighty":-4.538767,"marketCap":379773885},{"date":"2023-06-09","current":-6.116634,"twenty":-7.822824,"median":-5.586978,"eighty":-4.549103,"marketCap":487000254},{"date":"2023-06-16","current":-6.016566,"twenty":-7.801706,"median":-5.597041,"eighty":-4.554742,"marketCap":479032969},{"date":"2023-06-23","current":-6.667006,"twenty":-7.789638,"median":-5.618244,"eighty":-4.559517,"marketCap":530820317},{"date":"2023-06-30","current":-6.279244,"twenty":-7.759469,"median":-5.62503,"eighty":-4.565397,"marketCap":499947091},{"date":"2023-07-07","current":-6.658667,"twenty":-7.721758,"median":-5.636859,"eighty":-4.57261,"marketCap":530156377},{"date":"2023-07-14","current":-6.737887,"twenty":-7.69008,"median":-5.655758,"eighty":-4.584244,"marketCap":536463810},{"date":"2023-07-21","current":-7.325784,"twenty":-7.579961,"median":-5.662109,"eighty":-4.599308,"marketCap":583271606},{"date":"2023-07-28","current":-6.971378,"twenty":-7.548286,"median":-5.680564,"eighty":-4.620996,"marketCap":555054140},{"date":"2023-08-04","current":-6.024905,"twenty":-7.53565,"median":-5.7162,"eighty":-4.635607,"marketCap":479696910},{"date":"2023-08-11","current":-6.317571,"twenty":-7.508508,"median":-5.728214,"eighty":-4.646146,"marketCap":520365665},{"date":"2023-08-18","current":-6.081084,"twenty":-7.503806,"median":-5.74007,"eighty":-4.685973,"marketCap":500886743},{"date":"2023-08-25","current":-6.565311,"twenty":-7.485744,"median":-5.747894,"eighty":-4.706554,"marketCap":540771554},{"date":"2023-09-01","current":-5.939851,"twenty":-7.432417,"median":-5.767385,"eighty":-4.717317,"marketCap":489253674},{"date":"2023-09-08","current":-5.90757,"twenty":-7.394936,"median":-5.767385,"eighty":-4.729611,"marketCap":486594686},{"date":"2023-09-15","current":-6.125472,"twenty":-7.334123,"median":-5.776163,"eighty":-4.737938,"marketCap":504542851},{"date":"2023-09-22","current":-5.491941,"twenty":-7.325784,"median":-5.777303,"eighty":-4.750864,"marketCap":452360224},{"date":"2023-09-29","current":-6.528994,"twenty":-7.315985,"median":-5.798618,"eighty":-4.757855,"marketCap":537780193},{"date":"2023-10-06","current":-5.891429,"twenty":-7.305739,"median":-5.815592,"eighty":-4.762744,"marketCap":485265193},{"date":"2023-10-13","current":-5.245793,"twenty":-7.264602,"median":-5.81239,"eighty":-4.76989,"marketCap":432085446},{"date":"2023-10-20","current":-5.911605,"twenty":-7.242394,"median":-5.819157,"eighty":-4.778229,"marketCap":486927060},{"date":"2023-10-27","current":-5.61098,"twenty":-7.227384,"median":-5.819157,"eighty":-4.783375,"marketCap":462165240},{"date":"2023-11-03","current":-6.323198,"twenty":-7.199866,"median":-5.83392,"eighty":-4.792261,"marketCap":520829149},{"date":"2023-11-10","current":-24.667435,"twenty":-7.289284,"median":-5.845821,"eighty":-4.795681,"marketCap":537010063},{"date":"2023-11-17","current":-23.534356,"twenty":-7.370611,"median":-5.860692,"eighty":-4.801055,"marketCap":512342934},{"date":"2023-11-24","current":-17.593348,"twenty":-7.503806,"median":-5.888899,"eighty":-4.80845,"marketCap":383007177},{"date":"2023-12-01","current":-19.859506,"twenty":-7.579961,"median":-5.902072,"eighty":-4.82304,"marketCap":432341435},{"date":"2023-12-08","current":-20.456669,"twenty":-7.795672,"median":-5.911605,"eighty":-4.834509,"marketCap":445341678},{"date":"2023-12-15","current":-21.421317,"twenty":-7.911691,"median":-5.925612,"eighty":-4.846375,"marketCap":466342072},{"date":"2023-12-22","current":-22.600332,"twenty":-8.347461,"median":-5.932462,"eighty":-4.855589,"marketCap":492009220},{"date":"2023-12-29","current":-25.126791,"twenty":-8.454865,"median":-5.939851,"eighty":-4.857715,"marketCap":547010250},{"date":"2024-01-05","current":-21.5285,"twenty":-8.540017,"median":-5.941515,"eighty":-4.868537,"marketCap":468675449},{"date":"2024-01-12","current":-24.698059,"twenty":-8.846163,"median":-5.963335,"eighty":-4.891549,"marketCap":537676742},{"date":"2024-01-19","current":-22.952505,"twenty":-8.966963,"median":-5.978768,"eighty":-4.905676,"marketCap":499676030},{"date":"2024-01-26","current":-22.814698,"twenty":-9.138499,"median":-5.992309,"eighty":-4.915832,"marketCap":496675974},{"date":"2024-02-02","current":-22.615644,"twenty":-9.581677,"median":-6.004236,"eighty":-4.91911,"marketCap":492342559},{"date":"2024-02-09","current":-22.217535,"twenty":-10.307241,"median":-6.016566,"eighty":-4.921856,"marketCap":483675730},{"date":"2024-02-16","current":-22.99844,"twenty":-11.237955,"median":-6.024748,"eighty":-4.926434,"marketCap":500676049},{"date":"2024-02-23","current":-20.272926,"twenty":-11.577357,"median":-6.028302,"eighty":-4.929152,"marketCap":441341603},{"date":"2024-03-01","current":-20.257614,"twenty":-12.836913,"median":-6.037413,"eighty":-4.93164,"marketCap":441008264},{"date":"2024-03-08","current":-19.262342,"twenty":-13.485547,"median":-6.058862,"eighty":-4.948141,"marketCap":419341191},{"date":"2024-03-15","current":-61.321385,"twenty":-15.009082,"median":-6.081084,"eighty":-4.952685,"marketCap":409933456},{"date":"2024-03-22","current":-65.487505,"twenty":-17.593348,"median":-6.089351,"eighty":-4.961191,"marketCap":437783972},{"date":"2024-03-28","current":-69.405148,"twenty":-18.101359,"median":-6.099956,"eighty":-4.961191,"marketCap":463973412},{"date":"2024-04-05","current":-66.890118,"twenty":-18.959167,"median":-6.113366,"eighty":-4.968258,"marketCap":447160438},{"date":"2024-04-12","current":-64.133258,"twenty":-19.427711,"median":-6.12749,"eighty":-4.972184,"marketCap":428730832},{"date":"2024-04-19","current":-57.740708,"twenty":-19.862568,"median":-6.151102,"eighty":-4.983342,"marketCap":385996632},{"date":"2024-04-26","current":-59.922347,"twenty":-20.184117,"median":-6.16971,"eighty":-4.990199,"marketCap":400580888},{"date":"2024-05-03","current":-65.74005,"twenty":-20.444419,"median":-6.184272,"eighty":-4.992718,"marketCap":439472236},{"date":"2024-05-10","current":19.415556,"twenty":-20.444419,"median":-6.175043,"eighty":-4.972184,"marketCap":455974329},{"date":"2024-05-17","current":20.21327,"twenty":-20.380109,"median":-6.165519,"eighty":-4.951776,"marketCap":474708650},{"date":"2024-05-24","current":20.307914,"twenty":-20.2913,"median":-6.137664,"eighty":-4.92478,"marketCap":476931366},{"date":"2024-05-31","current":21.13267,"twenty":-20.263739,"median":-6.121053,"eighty":-4.910399,"marketCap":496300749},{"date":"2024-06-07","current":21.36252,"twenty":-20.202491,"median":-6.101682,"eighty":-4.850628,"marketCap":501698774},{"date":"2024-06-14","current":22.241358,"twenty":-20.073872,"median":-6.099956,"eighty":-4.811533,"marketCap":522338281},{"date":"2024-06-21","current":19.523721,"twenty":-19.926878,"median":-6.084547,"eighty":-4.791677,"marketCap":458514576},{"date":"2024-06-28","current":21.190193,"twenty":-19.908503,"median":-6.084547,"eighty":-4.774893,"marketCap":497651675},{"date":"2024-07-05","current":21.220101,"twenty":-19.884004,"median":-6.074028,"eighty":-4.75366,"marketCap":498354077},{"date":"2024-07-12","current":25.975557,"twenty":-19.868693,"median":-6.049635,"eighty":-4.708476,"marketCap":610035963},{"date":"2024-07-15","current":25.646563,"twenty":-19.86563,"median":-6.041344,"eighty":-4.695302,"marketCap":602309543},{"date":"2024-08-02","current":23.867006,"twenty":-19.862568,"median":-6.039378,"eighty":-4.672517,"marketCap":560516636},{"date":"2024-08-09","current":21.608912,"twenty":-19.826255,"median":-6.030346,"eighty":-4.59214,"marketCap":507485300},{"date":"2024-08-16","current":5.477968,"twenty":-19.64186,"median":-6.024748,"eighty":-4.554742,"marketCap":572140896},{"date":"2024-08-23","current":5.427433,"twenty":-19.500935,"median":-6.016566,"eighty":-4.515022,"marketCap":566862843},{"date":"2024-08-30","current":5.895722,"twenty":-19.427711,"median":-6.004236,"eighty":-4.471291,"marketCap":615772797},{"date":"2024-09-06","current":5.184866,"twenty":-19.32359,"median":-5.996942,"eighty":-4.404766,"marketCap":541528191},{"date":"2024-09-13","current":5.00631,"twenty":-19.188845,"median":-5.984239,"eighty":-4.33112,"marketCap":522879072},{"date":"2024-09-20","current":5.053476,"twenty":-19.038789,"median":-5.963335,"eighty":-4.288277,"marketCap":527805255},{"date":"2024-09-27","current":5.312888,"twenty":-18.96223,"median":-5.941515,"eighty":-4.265242,"marketCap":554899258},{"date":"2024-10-04","current":5.53861,"twenty":-18.944963,"median":-5.936157,"eighty":-4.226961,"marketCap":578474559},{"date":"2024-10-11","current":5.326364,"twenty":-18.856806,"median":-5.931781,"eighty":-4.189868,"marketCap":556306738},{"date":"2024-10-18","current":5.939519,"twenty":-18.609029,"median":-5.915524,"eighty":-4.126724,"marketCap":620347109},{"date":"2024-10-25","current":5.673369,"twenty":-18.19595,"median":-5.907226,"eighty":-4.100192,"marketCap":592549366},{"date":"2024-10-31","current":5.80476,"twenty":-17.843071,"median":-5.891429,"eighty":-4.019982,"marketCap":606272302},{"date":"2024-11-08","current":12.390042,"twenty":-17.597525,"median":-5.862704,"eighty":-3.976074,"marketCap":680845207},{"date":"2024-11-15","current":12.267624,"twenty":-17.595854,"median":-5.851076,"eighty":-3.881511,"marketCap":674118187},{"date":"2024-11-22","current":11.629759,"twenty":-17.593348,"median":-5.835599,"eighty":-3.819187,"marketCap":639066874},{"date":"2024-11-29","current":12.815285,"twenty":-17.245441,"median":-5.821992,"eighty":-3.767275,"marketCap":704212749},{"date":"2024-12-06","current":13.092338,"twenty":-15.736155,"median":-5.81239,"eighty":-3.495412,"marketCap":719437057},{"date":"2024-12-13","current":11.67486,"twenty":-15.214231,"median":-5.797942,"eighty":-3.367358,"marketCap":641545250},{"date":"2024-12-20","current":11.133642,"twenty":-14.879355,"median":-5.778442,"eighty":-3.167818,"marketCap":611804741},{"date":"2024-12-27","current":11.430023,"twenty":-14.360448,"median":-5.768112,"eighty":-2.950607,"marketCap":628091210},{"date":"2025-01-03","current":11.249617,"twenty":-13.956183,"median":-5.754982,"eighty":-2.907357,"marketCap":618177707},{"date":"2025-01-10","current":10.450675,"twenty":-13.687679,"median":-5.750196,"eighty":-2.871796,"marketCap":574275052},{"date":"2025-01-17","current":8.079622,"twenty":-13.52175,"median":-5.745698,"eighty":4.66739,"marketCap":443983302},{"date":"2025-01-24","current":8.324459,"twenty":-13.470462,"median":-5.734949,"eighty":4.930845,"marketCap":457437341},{"date":"2025-01-31","current":8.614397,"twenty":-13.333193,"median":-5.728214,"eighty":5.00631,"marketCap":473369756},{"date":"2025-02-07","current":8.685271,"twenty":-13.061672,"median":-5.704997,"eighty":5.067626,"marketCap":477264347},{"date":"2025-02-14","current":8.13761,"twenty":-12.882167,"median":-5.680564,"eighty":5.23877,"marketCap":447169785},{"date":"2025-02-21","current":8.421105,"twenty":-12.823337,"median":-5.663281,"eighty":5.326364,"marketCap":462748146},{"date":"2025-02-28","current":6.463236,"twenty":-12.636289,"median":-5.655945,"eighty":5.420021,"marketCap":424156296},{"date":"2025-03-07","current":5.656685,"twenty":-12.097773,"median":-5.638438,"eighty":5.496161,"marketCap":371225587},{"date":"2025-03-14","current":5.873832,"twenty":-11.969554,"median":-5.62503,"eighty":5.544674,"marketCap":385476089},{"date":"2025-03-21","current":5.651256,"twenty":-11.577357,"median":-5.617686,"eighty":5.571626,"marketCap":370869324},{"date":"2025-03-28","current":5.406965,"twenty":-11.517019,"median":-5.599973,"eighty":5.615422,"marketCap":354837509},{"date":"2025-04-04","current":4.353801,"twenty":-11.27265,"median":-5.589567,"eighty":5.571626,"marketCap":285722573},{"date":"2025-04-11","current":4.261514,"twenty":-11.237955,"median":-5.571525,"eighty":5.568257,"marketCap":279666109},{"date":"2025-04-17","current":4.266943,"twenty":-11.147449,"median":-5.559289,"eighty":5.565562,"marketCap":280022372},{"date":"2025-04-25","current":4.864097,"twenty":-11.079568,"median":-5.509464,"eighty":5.565562,"marketCap":319211253},{"date":"2025-05-02","current":4.962433,"twenty":-10.78542,"median":-5.491157,"eighty":5.545348,"marketCap":325664639},{"date":"2025-05-09","current":12.517294,"twenty":-10.332885,"median":-5.478703,"eighty":5.545348,"marketCap":310191070},{"date":"2025-05-16","current":11.552558,"twenty":-10.204667,"median":-5.459354,"eighty":5.5723,"marketCap":286283941},{"date":"2025-05-23","current":10.841194,"twenty":-10.031195,"median":-5.452073,"eighty":5.656685,"marketCap":268655619},{"date":"2025-05-30","current":11.239558,"twenty":-9.946722,"median":-5.429059,"eighty":5.695138,"marketCap":278527479},{"date":"2025-06-06","current":11.552558,"twenty":-9.702353,"median":-5.399443,"eighty":5.718514,"marketCap":286283941},{"date":"2025-06-13","current":11.168421,"twenty":-9.387087,"median":-5.353381,"eighty":5.773165,"marketCap":276764647},{"date":"2025-06-20","current":10.001784,"twenty":-9.232949,"median":-5.335361,"eighty":5.826994,"marketCap":247854200},{"date":"2025-06-27","current":9.987556,"twenty":-9.158624,"median":-5.321012,"eighty":5.856345,"marketCap":247501633},{"date":"2025-07-03","current":10.286329,"twenty":-9.145735,"median":-5.311468,"eighty":5.87166,"marketCap":254905528},{"date":"2025-07-11","current":9.617647,"twenty":-9.135788,"median":-5.304931,"eighty":5.919979,"marketCap":238334906},{"date":"2025-07-18","current":9.07701,"twenty":-9.127043,"median":-5.286124,"eighty":5.964912,"marketCap":224937382},{"date":"2025-07-25","current":9.091237,"twenty":-9.122507,"median":-5.284126,"eighty":6.126809,"marketCap":225289948},{"date":"2025-08-01","current":8.365645,"twenty":-9.060726,"median":-5.279034,"eighty":7.783241,"marketCap":207309060},{"date":"2025-08-08","current":-2.568826,"twenty":-8.957729,"median":-5.271746,"eighty":7.890195,"marketCap":188431117},{"date":"2025-08-15","current":-2.544592,"twenty":-8.921801,"median":-5.25003,"eighty":7.855403,"marketCap":186653465},{"date":"2025-08-22","current":-2.845096,"twenty":-8.884503,"median":-5.233243,"eighty":7.783241,"marketCap":208696350},{"date":"2025-08-29","current":-2.738466,"twenty":-8.846163,"median":-5.226635,"eighty":7.239487,"marketCap":200874681},{"date":"2025-09-05","current":-2.530052,"twenty":-8.844007,"median":-5.219365,"eighty":6.478122,"marketCap":185586874},{"date":"2025-09-12","current":-2.583367,"twenty":-8.817897,"median":-5.209215,"eighty":6.400728,"marketCap":189497708},{"date":"2025-09-19","current":-2.689997,"twenty":-8.689404,"median":-5.18342,"eighty":6.138752,"marketCap":197319377},{"date":"2025-09-26","current":-2.704538,"twenty":-8.540746,"median":-5.163374,"eighty":6.074163,"marketCap":198385968},{"date":"2025-10-03","current":-2.869331,"twenty":-8.521236,"median":-5.151903,"eighty":6.002856,"marketCap":210474002},{"date":"2025-10-10","current":-3.291006,"twenty":-8.454865,"median":-5.136156,"eighty":5.982572,"marketCap":241405148},{"date":"2025-10-17","current":-2.995348,"twenty":-8.451848,"median":-5.106483,"eighty":5.965516,"marketCap":219717793},{"date":"2025-10-24","current":-3.101979,"twenty":-8.421679,"median":-5.09094,"eighty":5.960407,"marketCap":227539462},{"date":"2025-10-31","current":-3.344321,"twenty":-8.347461,"median":-5.083828,"eighty":5.947605,"marketCap":245315982},{"date":"2025-11-07","current":-2.388417,"twenty":-8.284705,"median":-5.064425,"eighty":5.937498,"marketCap":247093634},{"date":"2025-11-14","current":-3.043492,"twenty":-8.046074,"median":-5.04517,"eighty":5.924695,"marketCap":314864470},{"date":"2025-11-21","current":-3.178681,"twenty":-7.966471,"median":-5.003716,"eighty":5.903808,"marketCap":328850477},{"date":"2025-11-28","current":-3.559984,"twenty":-7.913544,"median":-4.993085,"eighty":5.895722,"marketCap":368298190},{"date":"2025-12-05","current":-3.521854,"twenty":-7.90428,"median":-4.979361,"eighty":5.875508,"marketCap":364353419},{"date":"2025-12-12","current":-3.74717,"twenty":-7.859027,"median":-4.961191,"eighty":5.873832,"marketCap":387663431},{"date":"2025-12-19","current":-3.799165,"twenty":-7.813773,"median":-4.950413,"eighty":5.868403,"marketCap":393042664},{"date":"2025-12-26","current":-3.667443,"twenty":-7.801706,"median":-4.930396,"eighty":5.868403,"marketCap":379415273},{"date":"2026-01-02","current":-3.563451,"twenty":-7.789638,"median":-4.923318,"eighty":5.865146,"marketCap":368656805},{"date":"2026-01-09","current":-3.646644,"twenty":-7.747401,"median":-4.915123,"eighty":5.856345,"marketCap":377263579},{"date":"2026-01-16","current":-3.750636,"twenty":-7.718741,"median":-4.871065,"eighty":5.848783,"marketCap":388022046},{"date":"2026-01-23","current":-4.059145,"twenty":-7.664436,"median":-4.849564,"eighty":5.842345,"marketCap":419938832},{"date":"2026-01-30","current":-4.041813,"twenty":-7.572419,"median":-4.820781,"eighty":5.835531,"marketCap":418145754},{"date":"2026-02-06","current":-3.490657,"twenty":-7.546777,"median":-4.796098,"eighty":5.82969,"marketCap":361125878},{"date":"2026-02-13","current":-3.743703,"twenty":-7.529048,"median":-4.778229,"eighty":5.814866,"marketCap":387304815},{"date":"2026-02-20","current":-3.955153,"twenty":-7.508508,"median":-4.762744,"eighty":5.800117,"marketCap":409180365}],"updateTime":1771686303790},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRDA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612443829","title":"Entrada Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2612443829","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612443829?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:21","pubTimestamp":1771417260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2026 07:21 ET (12:21 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA"],"gpt_icon":0},{"id":"2612410930","title":"Advancing DMD and DM1 Pipeline Positions Entrada for Multiple Near‑Term Catalysts and Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2612410930","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612410930?lang=en_us&edition=fundamental","pubTime":"2026-02-18 19:36","pubTimestamp":1771414580,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from H.C. Wainwright r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/advancing-dmd-and-dm1-pipeline-positions-entrada-for-multiple-near‑term-catalysts-and-upside-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/advancing-dmd-and-dm1-pipeline-positions-entrada-for-multiple-near‑term-catalysts-and-upside-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRDA","BK4581","BK4585","XBI","BK4139","LABU","XLV","BK4588"],"gpt_icon":0},{"id":"2612292490","title":"Roth MKM Keeps Their Buy Rating on Entrada Therapeutics Inc (TRDA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2612292490","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612292490?lang=en_us&edition=fundamental","pubTime":"2026-02-18 11:55","pubTimestamp":1771386916,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on Entrada Therapeutics Inc, with a price target of $13...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-entrada-therapeutics-inc-trda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-keeps-their-buy-rating-on-entrada-therapeutics-inc-trda-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRDA"],"gpt_icon":0},{"id":"2612694204","title":"Entrada Therapeutics: Advancing ENTR-601-44 Positions Platform for Best-in-Class Dystrophin Restoration and Attractive Risk/Reward","url":"https://stock-news.laohu8.com/highlight/detail?id=2612694204","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612694204?lang=en_us&edition=fundamental","pubTime":"2026-02-18 01:05","pubTimestamp":1771347930,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has maintained their bullish stance on TRDA stock, giving a Buy rating on February 10. Myles Minter has given hi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-advancing-entr-601-44-positions-platform-for-best-in-class-dystrophin-restoration-and-attractive-risk-reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-advancing-entr-601-44-positions-platform-for-best-in-class-dystrophin-restoration-and-attractive-risk-reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRDA","ENTR"],"gpt_icon":0},{"id":"2612454588","title":"BRIEF-Entrada Therapeutics Inc On Track To Report Elevate-44-201 Cohort 1 Data In Q2 2026, Cohort 2 Data By End Of Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2612454588","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612454588?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:27","pubTimestamp":1771331266,"startTime":"0","endTime":"0","summary":"BRIEF-Entrada Therapeutics Inc On Track To Report Elevate-44-201 Cohort 1 Data In Q2 2026, Cohort 2Data By End Of YearFeb 17 (Reuters) - Entrada Therapeutics Inc TRDA.O:ENTRADA THERAPEUTICS INC - ON T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0RX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2612451283","title":"Entrada Therapeutics Inc - Intends to Open Expansion Cohort Later This Year in Elevate-44-201 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2612451283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612451283?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:09","pubTimestamp":1771330182,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0RX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2612451369","title":"Entrada Therapeutics Advances ELEVATE-44-201 Study to Higher Dose for Duchenne Muscular Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2612451369","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612451369?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:00","pubTimestamp":1771329643,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc. announced that an independent Data Monitoring Committee has recommended the initiation of Cohort 2 at a 12 mg/kg dose in the ELEVATE-44-201 Phase 1/2 clinical trial of ENTR-601-44 for Duchenne muscular dystrophy patients amenable to exon 44 skipping. The company has completed dosing for Cohort 1 at 6 mg/kg, with data from this cohort expected in the second quarter of 2026. Data from Cohort 2 are anticipated by the end of the year. No clinical results have been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 17, 2026, and is solely responsible for the information contained there","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL3bxBHw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4588","TRDA","BK4585","BK4139","BK4112","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014005.SGD","LU2210149790.SGD","NDAQ","LU2210150020.SGD","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","SG9999014021.USD"],"gpt_icon":0},{"id":"2612789451","title":"Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2612789451","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612789451?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:00","pubTimestamp":1771329600,"startTime":"0","endTime":"0","summary":"-- Patients in Cohort 1 have progressed to the open label, Phase 2 portion of ELEVATE-44-201-- -- Company on track to report ELEVATE-44-201 Cohort 1 data in Q2 2026, with Cohort 2data by end of year -","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/17/3239084/0/en/Independent-Data-Monitoring-Committee-Recommends-Initiation-of-Cohort-2-at-the-Increased-Dose-of-12-mg-kg-in-Entrada-Therapeutics-ELEVATE-44-201-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2610995959","title":"Entrada Therapeutics Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2610995959","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610995959?lang=en_us&edition=fundamental","pubTime":"2026-02-11 23:01","pubTimestamp":1770822060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2026 10:01 ET (15:01 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2610132932","title":"Guggenheim Initiates Coverage on Entrada Therapeutics With Buy Rating, $20 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2610132932","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610132932?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:22","pubTimestamp":1770812538,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc (TRDA) has an average rating of Buy and mean price target of $18.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRDA"],"gpt_icon":0},{"id":"2608361365","title":"Entrada Therapeutics to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2608361365","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608361365?lang=en_us&edition=fundamental","pubTime":"2026-02-04 20:00","pubTimestamp":1770206400,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  04, 2026  (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the Company will participate in two upcoming investor conferences. Guggenheim Emerging Outlook: Bi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/04/3231902/0/en/Entrada-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2606716577","title":"Oppenheimer Initiates Coverage on Entrada Therapeutics With Outperform Rating, $21 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2606716577","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606716577?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:24","pubTimestamp":1769603060,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc (TRDA) has an average rating of Buy and mean price target of $18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRDA","OPY"],"gpt_icon":0},{"id":"2603521707","title":"Entrada Therapeutics: Advancing DMD and DM1 Pipeline with Emerging Ophthalmology Assets Supports Buy Rating and $20 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2603521707","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603521707?lang=en_us&edition=fundamental","pubTime":"2026-01-13 06:35","pubTimestamp":1768257319,"startTime":"0","endTime":"0","summary":"Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Entrada Therapeutics Inc. The associated price target remains the same...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-advancing-dmd-and-dm1-pipeline-with-emerging-ophthalmology-assets-supports-buy-rating-and-20-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-advancing-dmd-and-dm1-pipeline-with-emerging-ophthalmology-assets-supports-buy-rating-and-20-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRDA"],"gpt_icon":0},{"id":"2601921361","title":"Entrada Therapeutics unveils pipeline advances for Duchenne and myotonic dystrophy therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2601921361","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601921361?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:47","pubTimestamp":1767876434,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc. provided an update on its expanding pipeline of intracellular therapeutics, highlighting several clinical-stage programs targeting diseases with significant unmet medical needs. The company’s Duchenne muscular dystrophy  franchise includes multiple candidates, with clinical data expected for ENTR-601-44 and ENTR-601-45 in 2026. Additionally, ENTR-601-50 has received authorization for a Phase 1/2 study in the U.K., with a European Union filing anticipated later in the year. The myotonic dystrophy type 1  program, partnered with Vertex, has progressed to the multiple ascending dose phase, with completion of enrollment and dosing expected in the first half of 2026. The company is utilizing ex-U.S. clinical data to inform discussions with regulatory agencies regarding potential accelerated approval pathways and plans to initiate global registrational studies for broader approval. You can access the full presentation through the link below.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL3B2G6r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2601536994","title":"Entrada Therapeutics reports progress across development portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2601536994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601536994?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:16","pubTimestamp":1767874570,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics (TRDA) reported progress across its robust development portfolio of RNA-based programs for the potential treatment of neuromus...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/entrada-therapeutics-reports-progress-across-development-portfolio-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/entrada-therapeutics-reports-progress-across-development-portfolio-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IE0009354923.USD","RNA","BK4505","TRDA","BK4585","BK4139"],"gpt_icon":0},{"id":"2601698463","title":"Entrada Therapeutics Inc - Has Cash Runway Into Q3 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2601698463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601698463?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:09","pubTimestamp":1767874156,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y81RN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2601369869","title":"Entrada Therapeutics Inc - Expects to Initiate Global Phase 1/2 Mad Clinical Study of Entr-601-50 by End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369869?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:09","pubTimestamp":1767874156,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y81RN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2601036986","title":"Entrada Therapeutics Inc - on Track to Report Elevate-44-201 Data From First Cohort in Q2 2026 and Elevate-45-201 Data From First Cohort in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601036986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601036986?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:09","pubTimestamp":1767874156,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y81RN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2601369386","title":"Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369386","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369386?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873600,"startTime":"0","endTime":"0","summary":"-- Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 – -- Expects to initiate global Phase 1/2 MAD clinical stud","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/08/3215189/0/en/Entrada-Therapeutics-Highlights-Progress-Across-its-Portfolio-of-RNA-based-Therapeutics-for-the-Treatment-of-Neuromuscular-and-Ocular-Diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0009354923.USD","LU2065732104.USD","RNA","BK4505","PRGS","TRDA","BK4585","BK4139","BK4097"],"gpt_icon":0},{"id":"2591962511","title":"Entrada Therapeutics Unveils Pipeline Progress and Clinical Milestones for Duchenne and Myotonic Dystrophy Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2591962511","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591962511?lang=en_us&edition=fundamental","pubTime":"2025-12-16 01:45","pubTimestamp":1765820739,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc. has provided an update on its clinical development pipeline, outlining plans to advance four clinical-stage programs by the end of 2025. Key milestones expected in 2026 include data readouts for ENTR-601-44 and ENTR-601-45, as well as progress on ENTR-601-50 and Vertex-partnered VX-670 for myotonic dystrophy type 1 . The company highlighted its strategy around its EEV platform, emphasizing improvements in endosomal escape and the development of novel PMO conjugates. Entrada also noted that ongoing and planned ex-U.S. studies are designed to generate data supporting future regulatory discussions and potential accelerated approval pathways. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDLG6xjk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRDA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}]}}